SEPTERNA INC (SEPN) Fundamental Analysis & Valuation

NASDAQ:SEPN • US81734D1046

Current stock price

23.09 USD
-1.74 (-7.01%)
At close:
23.09 USD
0 (0%)
After Hours:

This SEPN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. SEPN Profitability Analysis

1.1 Basic Checks

  • In the past year SEPN has reported negative net income.
  • SEPN had a positive operating cash flow in the past year.
SEPN Yearly Net Income VS EBIT VS OCF VS FCFSEPN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -8.20%, SEPN is in the better half of the industry, outperforming 71.50% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -12.80%, SEPN is in the better half of the industry, outperforming 73.06% of the companies in the same industry.
Industry RankSector Rank
ROA -8.2%
ROE -12.8%
ROIC N/A
ROA(3y)-7.83%
ROA(5y)N/A
ROE(3y)-9.79%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEPN Yearly ROA, ROE, ROICSEPN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2022 2023 2024 2025 0 -20 -40 -60 -80

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for SEPN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SEPN Yearly Profit, Operating, Gross MarginsSEPN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2022 2023 2024 2025 0 -10K -20K -30K

7

2. SEPN Health Analysis

2.1 Basic Checks

  • SEPN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for SEPN has been increased compared to 1 year ago.
  • There is no outstanding debt for SEPN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SEPN Yearly Shares OutstandingSEPN Yearly Shares OutstandingYearly Shares Outstanding 2022 2023 2024 2025 10M 20M 30M 40M
SEPN Yearly Total Debt VS Total AssetsSEPN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • An Altman-Z score of 2.79 indicates that SEPN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.79, SEPN is in the better half of the industry, outperforming 65.28% of the companies in the same industry.
  • SEPN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2.79
ROIC/WACCN/A
WACC9.34%
SEPN Yearly LT Debt VS Equity VS FCFSEPN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2022 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • SEPN has a Current Ratio of 4.73. This indicates that SEPN is financially healthy and has no problem in meeting its short term obligations.
  • SEPN has a Current ratio of 4.73. This is in the better half of the industry: SEPN outperforms 63.21% of its industry peers.
  • A Quick Ratio of 4.73 indicates that SEPN has no problem at all paying its short term obligations.
  • SEPN has a better Quick ratio (4.73) than 64.77% of its industry peers.
Industry RankSector Rank
Current Ratio 4.73
Quick Ratio 4.73
SEPN Yearly Current Assets VS Current LiabilitesSEPN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2022 2023 2024 2025 100M 200M 300M 400M

3

3. SEPN Growth Analysis

3.1 Past

  • SEPN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 84.79%, which is quite impressive.
  • The Revenue has grown by 4174.51% in the past year. This is a very strong growth!
EPS 1Y (TTM)84.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.5%
Revenue 1Y (TTM)4174.51%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11276.42%

3.2 Future

  • SEPN is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -18.76% yearly.
  • The Revenue is expected to grow by 17.34% on average over the next years. This is quite good.
EPS Next Y-21.4%
EPS Next 2Y-32.39%
EPS Next 3Y-26.89%
EPS Next 5Y-18.76%
Revenue Next Year92.66%
Revenue Next 2Y32.48%
Revenue Next 3Y18.47%
Revenue Next 5Y17.34%

3.3 Evolution

SEPN Yearly Revenue VS EstimatesSEPN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M
SEPN Yearly EPS VS EstimatesSEPN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -2 -4 -6

2

4. SEPN Valuation Analysis

4.1 Price/Earnings Ratio

  • SEPN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SEPN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEPN Price Earnings VS Forward Price EarningsSEPN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, SEPN is valued cheaply inside the industry as 91.71% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 9.46
EV/EBITDA N/A
SEPN Per share dataSEPN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • SEPN's earnings are expected to decrease with -26.89% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-32.39%
EPS Next 3Y-26.89%

0

5. SEPN Dividend Analysis

5.1 Amount

  • No dividends for SEPN!.
Industry RankSector Rank
Dividend Yield 0%

SEPN Fundamentals: All Metrics, Ratios and Statistics

SEPTERNA INC

NASDAQ:SEPN (4/10/2026, 8:00:02 PM)

After market: 23.09 0 (0%)

23.09

-1.74 (-7.01%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-09
Earnings (Next)05-13
Inst Owners102.02%
Inst Owner Change0%
Ins Owners3.22%
Ins Owner Change-0.06%
Market Cap1.04B
Revenue(TTM)45.95M
Net Income(TTM)-48.88M
Analysts82.86
Price Target46.41 (101%)
Short Float %4.83%
Short Ratio6.99
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-51.92%
Min EPS beat(2)-111.11%
Max EPS beat(2)7.27%
EPS beat(4)1
Avg EPS beat(4)-68.76%
Min EPS beat(4)-163.84%
Max EPS beat(4)7.27%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-1.69%
Min Revenue beat(2)-39.79%
Max Revenue beat(2)36.41%
Revenue beat(4)2
Avg Revenue beat(4)3.09%
Min Revenue beat(4)-98.97%
Max Revenue beat(4)114.71%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)34.39%
PT rev (3m)50.66%
EPS NQ rev (1m)-16.8%
EPS NQ rev (3m)-83.81%
EPS NY rev (1m)-32.33%
EPS NY rev (3m)-71.09%
Revenue NQ rev (1m)5.11%
Revenue NQ rev (3m)-6.34%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-12.05%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 22.57
P/FCF 9.46
P/OCF 9.41
P/B 2.72
P/tB 2.72
EV/EBITDA N/A
EPS(TTM)-1.38
EYN/A
EPS(NY)-1.68
Fwd EYN/A
FCF(TTM)2.44
FCFY10.58%
OCF(TTM)2.45
OCFY10.63%
SpS1.02
BVpS8.5
TBVpS8.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.2%
ROE -12.8%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM 238.67%
ROA(3y)-7.83%
ROA(5y)N/A
ROE(3y)-9.79%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 32.29%
Cap/Sales 1.13%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.73
Quick Ratio 4.73
Altman-Z 2.79
F-Score6
WACC9.34%
ROIC/WACCN/A
Cap/Depr(3y)173.93%
Cap/Depr(5y)N/A
Cap/Sales(3y)700.91%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%62.5%
EPS Next Y-21.4%
EPS Next 2Y-32.39%
EPS Next 3Y-26.89%
EPS Next 5Y-18.76%
Revenue 1Y (TTM)4174.51%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11276.42%
Revenue Next Year92.66%
Revenue Next 2Y32.48%
Revenue Next 3Y18.47%
Revenue Next 5Y17.34%
EBIT growth 1Y0.03%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year2.39%
EBIT Next 3Y-32.02%
EBIT Next 5YN/A
FCF growth 1Y257.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y263.32%
OCF growth 3YN/A
OCF growth 5YN/A

SEPTERNA INC / SEPN Fundamental Analysis FAQ

What is the fundamental rating for SEPN stock?

ChartMill assigns a fundamental rating of 3 / 10 to SEPN.


Can you provide the valuation status for SEPTERNA INC?

ChartMill assigns a valuation rating of 2 / 10 to SEPTERNA INC (SEPN). This can be considered as Overvalued.


How profitable is SEPTERNA INC (SEPN) stock?

SEPTERNA INC (SEPN) has a profitability rating of 1 / 10.


What is the financial health of SEPTERNA INC (SEPN) stock?

The financial health rating of SEPTERNA INC (SEPN) is 7 / 10.